yale

AMA Update 450: Akiko Iwasaki on what causes long COVID, brain fog, the Yale Paxlovid study and long COVID treatments

What causes long COVID? Is long COVID dangerous? Who is most likely to get long COVID? Any pediatric long COVID news? What can be done for long term COVID?

Our guest is Akiko Iwasaki, PhD, Sterling Professor of Immunobiology at Yale University. American Medical Association CXO Todd Unger hosts.

🏆 Check out Yale Immunologist Akiko Iwasaki on TIME’s Most Influential People 2024: https://time.com/6964230/akiko-iwasaki/

🔬 Keep up with new COVID research from Iwasaki Lab Yale: https://medicine.yale.edu/lab/iwasaki/news/

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 391: The latest long COVID research on symptoms, testing and treatments with Akiko Iwasaki, PhD

Leading long COVID researcher, Akiko Iwasaki, PhD, sterling professor of immunobiology at Yale University, joins to provide an update on the latest long COVID studies and clinical trials—and what their findings mean for physicians and patients. Dr. Iwasaki discusses what we know now about the causes of long COVID, the ongoing challenges with diagnosing it and the timeline for potential treatments. American Medical Association CXO Todd Unger hosts.

🎞️ Watch Dr. Iwasaki’s previous episode here: https://youtu.be/kONtiiHsbPw?si=TMIr95DMfvuYDF3f

🔬 Distinguishing features of long COVID identified through immune profiling published in Nature: https://www.nature.com/articles/s41586-023-06651-y

📰 Scientists Offer a New Explanation for Long Covid New York Times article: https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 301: Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD

Akiko Iwasaki, PhD, returns to AMA Update to share the latest science behind long COVID, including how many people are still suffering, most common symptoms and what we know about treatments like Paxlovid. She also shares guidance for physicians on diagnosing long COVID, treating post-COVID patients and new research to watch. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 139: Akiko Iwasaki, PhD, on the latest long COVID research

AMA CXO Todd Unger discusses the latest research on long COVID with Akiko Iwasaki, PhD, the Sterling Professor of Immunobiology at Yale University and a principal investigator at the Howard Hughes Medical Institute.

Read More